Product Information
DEXTROAMP-AMPHET ER 25 MG CAP is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $0.4895 per EA under NDC 43975028110. Its NADAC has been published 321 times since Aug 12, 2020.
FDA first approved this application on Jan 22, 2019. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
DEXTROAMP-AMPHET ER 25 MG CAP
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine SulfateStrength
6.25; 6.25; 6.25; 6.25 mg/1; mg/1; mg/1; mg/1
Manufacturer
ANI Pharmaceuticals, Inc.NDC
43975028110
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
AMPHETAMINE DL-ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA205401FDA Approved
1/22/2019
TE Code
AB1
On Market Since
3/16/2020
Pharmacological Classes
Price Statistics
The NADAC for DEXTROAMP-AMPHET ER 25 MG CAP has been published 321 times since Aug 12, 2020, and over the history we have for it it has declined 50.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4895 per EA |
|---|---|
| All-time high | $1.1343 (Sep 16, 2020) |
| All-time low | $0.4173 (May 22, 2024) |
| 52-week high | $0.5584 |
| 52-week low | $0.4895 |
| Median price | $0.5944 |
| Average price | $0.6155 |
| Largest weekly change | +30.3% (Dec 18, 2024) |
| Weeks tracked | 321 |
| Tracking since | Aug 12, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
ANI Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central Nervous System Stimulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DEXTROAMP-AMPHET ER 25 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHET ER 25 MG CAP, manufactured by ANI Pharmaceuticals, Inc., is $0.4895 per EA (NDC 43975028110), effective Sep 30, 2026.
How has the price of DEXTROAMP-AMPHET ER 25 MG CAP changed over time?
Over the history we have for it, the NADAC for DEXTROAMP-AMPHET ER 25 MG CAP has declined 50.6%. It has been tracked across 321 weekly CMS publications since Aug 12, 2020.
What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHET ER 25 MG CAP?
Since Aug 12, 2020, the NADAC for DEXTROAMP-AMPHET ER 25 MG CAP has ranged from a low of $0.4173 (May 22, 2024) to a high of $1.1343 (Sep 16, 2020), with a median of $0.5944 per EA.
Are there cheaper alternatives to DEXTROAMP-AMPHET ER 25 MG CAP?
No other NADAC-published product currently shares the active ingredient and strength of DEXTROAMP-AMPHET ER 25 MG CAP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DEXTROAMP-AMPHET ER 25 MG CAP?
DEXTROAMP-AMPHET ER 25 MG CAP (NDC 43975028110) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.